Advocacy at a Glance 7/15/12 Advocacy at a Glance 7/15/12 Office of Management and Budget Meeting and more Read More Analysis and Commentary 6/28/12 Analysis and Commentary 6/28/12 A Delay Until July ... And What May Happen Read More Analysis and Commentary 6/28/12 Analysis and Commentary 6/28/12 It's Not a "Normal" Year ... And So ... Read More Analysis and Commentary 6/22/12 Analysis and Commentary 6/22/12 What If There's a Sequester? Read More Analysis and Commentary 6/10/12 Analysis and Commentary 6/10/12 The FDA's Best Case, Optimistic Scenario for FY 13 Read More Advocacy at a Glance 6/10/12 Advocacy at a Glance 6/10/12 FDA Receives 2.481 Billion in House Appropriations Agriculture Subcommittee Mark-Up and more Read More Advocacy at a Glance 6/5/12 Advocacy at a Glance 6/5/12 House Subcommittee Appropriations Committee Mark for FY 13 Budget Authority Appropriations for FDA and more Read More Analysis and Commentary 6/1/12 Analysis and Commentary 6/1/12 Will Congress Actually Stand Behind its Own Words? Read More Advocacy at a Glance 6/1/12 Advocacy at a Glance 6/1/12 House Appropriations Agriculture Subcommittee Mark Up of FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Read More Analysis and Commentary 5/19/12 Analysis and Commentary 5/19/12 Pre-sequester Funding Situation for FDA in FY 13 Getting Clearer Read More Advocacy at a Glance 5/19/12 Advocacy at a Glance 5/19/12 Senate Releases CBO Report Scoring Costs of PDUFA Legislation and more Read More Analysis and Commentary 5/11/12 Analysis and Commentary 5/11/12 Preliminary Positioning and the 2013 Budget Cuts: The FDA Should Remain an Exception Read More Advocacy at a Glance 5/11/12 Advocacy at a Glance 5/11/12 Commissioner Hamburg Presents to Alliance Quarterly Membership Meeting and more Read More Analysis and Commentary 5/4/12 Analysis and Commentary 5/4/12 Why Commissioner Hamburg is Already Talking About the FY 14 Budget Read More Analysis and Commentary, Uncategorized 4/30/12 Analysis and Commentary, Uncategorized 4/30/12 Senate Appropriations Committee Adopts $24 Million Increase for FDA Read More Advocacy at a Glance 4/30/12 Advocacy at a Glance 4/30/12 Senate Appropriations Committee Mark-up and more Read More Uncategorized 4/26/12 Uncategorized 4/26/12 Alliance Urges Congress to Increase FDA Funding Read More Analysis and Commentary 4/23/12 Analysis and Commentary 4/23/12 FDA Appropriations Off to a Fast Start Read More Advocacy at a Glance 4/23/12 Advocacy at a Glance 4/23/12 Senate Mark Up for Agriculture/FDA Possible in Near-Term and more Read More Analysis and Commentary 4/13/12 Analysis and Commentary 4/13/12 FDA's Proposed BA and User Fee Funding for FY 13 Read More Newer Posts Older Posts
Advocacy at a Glance 7/15/12 Advocacy at a Glance 7/15/12 Office of Management and Budget Meeting and more Read More
Analysis and Commentary 6/28/12 Analysis and Commentary 6/28/12 A Delay Until July ... And What May Happen Read More
Analysis and Commentary 6/28/12 Analysis and Commentary 6/28/12 It's Not a "Normal" Year ... And So ... Read More
Analysis and Commentary 6/22/12 Analysis and Commentary 6/22/12 What If There's a Sequester? Read More
Analysis and Commentary 6/10/12 Analysis and Commentary 6/10/12 The FDA's Best Case, Optimistic Scenario for FY 13 Read More
Advocacy at a Glance 6/10/12 Advocacy at a Glance 6/10/12 FDA Receives 2.481 Billion in House Appropriations Agriculture Subcommittee Mark-Up and more Read More
Advocacy at a Glance 6/5/12 Advocacy at a Glance 6/5/12 House Subcommittee Appropriations Committee Mark for FY 13 Budget Authority Appropriations for FDA and more Read More
Analysis and Commentary 6/1/12 Analysis and Commentary 6/1/12 Will Congress Actually Stand Behind its Own Words? Read More
Advocacy at a Glance 6/1/12 Advocacy at a Glance 6/1/12 House Appropriations Agriculture Subcommittee Mark Up of FY 2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Read More
Analysis and Commentary 5/19/12 Analysis and Commentary 5/19/12 Pre-sequester Funding Situation for FDA in FY 13 Getting Clearer Read More
Advocacy at a Glance 5/19/12 Advocacy at a Glance 5/19/12 Senate Releases CBO Report Scoring Costs of PDUFA Legislation and more Read More
Analysis and Commentary 5/11/12 Analysis and Commentary 5/11/12 Preliminary Positioning and the 2013 Budget Cuts: The FDA Should Remain an Exception Read More
Advocacy at a Glance 5/11/12 Advocacy at a Glance 5/11/12 Commissioner Hamburg Presents to Alliance Quarterly Membership Meeting and more Read More
Analysis and Commentary 5/4/12 Analysis and Commentary 5/4/12 Why Commissioner Hamburg is Already Talking About the FY 14 Budget Read More
Analysis and Commentary, Uncategorized 4/30/12 Analysis and Commentary, Uncategorized 4/30/12 Senate Appropriations Committee Adopts $24 Million Increase for FDA Read More
Advocacy at a Glance 4/30/12 Advocacy at a Glance 4/30/12 Senate Appropriations Committee Mark-up and more Read More
Uncategorized 4/26/12 Uncategorized 4/26/12 Alliance Urges Congress to Increase FDA Funding Read More
Analysis and Commentary 4/23/12 Analysis and Commentary 4/23/12 FDA Appropriations Off to a Fast Start Read More
Advocacy at a Glance 4/23/12 Advocacy at a Glance 4/23/12 Senate Mark Up for Agriculture/FDA Possible in Near-Term and more Read More
Analysis and Commentary 4/13/12 Analysis and Commentary 4/13/12 FDA's Proposed BA and User Fee Funding for FY 13 Read More
